Literature DB >> 6685136

Glomerular prostaglandin and thromboxane synthesis in rat nephrotoxic serum nephritis. Effects on renal hemodynamics.

E A Lianos, G A Andres, M J Dunn.   

Abstract

Glomerular arachidonate cyclooxygenation by isolated rat glomeruli was assessed in vitro in antiglomerular basement membrane (anti-GBM) antibody-induced glomerulonephritis by radioimmunoassay for prostaglandins (PG) and thromboxane. After a single intravenous injection of rabbit anti-rat GBM serum, we observed enhancement of glomerular thromboxane B2 (TxB2) synthesis as early as 2 to 3 h with smaller increments in PGF2 alpha, PGE2 and 6-keto-PGF1 alpha synthetic rates. On day 2 of the disease, the glomerular synthesis of TxB2 and, to a lesser extent, PGF2 alpha and PGE2 remained enhanced, whereas on days 8, 11, and 14, TxB2 was the only prostanoid synthesized at increased rates. Glomerular TxB2 synthesis correlated with the presacrifice 24-h protein excretion. 60 min after intravenous infusion of anti-GMB serum, glomerular filtration rate (GFR) decreased (0.66 +/- 0.04 to 0.44 +/- 0.03 ml/min per 100 g, P less than 0.05), without a significant change in renal plasma flow (RPF): 1.97 +/- 0.23 to 1.80 +/- 0.23 ml/min per 100 g) and without a change in glomerular PG synthetic rates. At 2 h, GFR and RPF reached a nadir (0.25 +/- 0.04 and 1.3 +/- 0.1 ml/min per 100 g, respectively) coinciding with a fivefold increment in glomerular TxB2. By 3 h GFR and RPF partially recovered to 0.43 +/- 0.07 and 1.77 +/- 0.20 ml/min per 100 g, respectively, P less than 0.05, despite further increments in TxB2 synthesis. This recovery of GFR and RPF coincided with increments in vasodilatory PG, (PGE2 and PGI2). The thromboxane synthetase inhibitor OKY-1581 markedly inhibited platelet and glomerular TxB2 synthesis and preserved GFR at 1, 2, and 3 h. Another thromboxane synthetase inhibitor, UK-38485, also completely inhibited platelet and glomerular TxB2 synthesis and prevented decrements of GFR at 2 and 3 h. A cyclooxygenase inhibitor, ibuprofen, inhibited platelet TxB2 and PGE2 synthesis and significantly reduced glomerular PGE2 but not TxB2 synthesis. In the ibuprofen-treated rats, the partial recoveries of GFR and RPF at 3 h were attenuated. The in vitro glomerular TxB2 synthesis correlated inversely with the presacrifice GFR and filtration fraction. These observations indicate that in anti-GBM nephritis there is enhanced synthesis of TxA2 and PG in the glomerulus that mediate changes in renal hemodynamics.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6685136      PMCID: PMC370428          DOI: 10.1172/JCI111100

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  36 in total

1.  Identification of an enzyme in platelet microsomes which generates thromboxane A2 from prostaglandin endoperoxides.

Authors:  P Needleman; S Moncada; S Bunting; J R Vane; M Hamberg; B Samuelsson
Journal:  Nature       Date:  1976-06-17       Impact factor: 49.962

2.  Administration to man of UK-37,248-01, a selective inhibitor of thromboxane synthetase.

Authors:  H M Tyler; C A Saxton; M J Parry
Journal:  Lancet       Date:  1981-03-21       Impact factor: 79.321

3.  Pharmacological control of prostaglandin and thromboxane release from macrophages.

Authors:  K Brune; M Glatt; H Kälin; B A Peskar
Journal:  Nature       Date:  1978-07-20       Impact factor: 49.962

4.  Exfoliation of endothelial cytoplasms in nephrotoxic serum nephritis. A study using antiserum against water-soluble glycoprotein isolated from the glomerular basement membrane.

Authors:  S Shibata; H Sakaguchi; T Nagasawa
Journal:  Lab Invest       Date:  1978-02       Impact factor: 5.662

5.  Radioimmunoassay of prostaglandins Falpha, E1 and E2 in human plasma.

Authors:  F Dray; B Charbonnel; J Maclouf
Journal:  Eur J Clin Invest       Date:  1975-07-29       Impact factor: 4.686

6.  The effect of arginine vasopressin and its analogs on the synthesis of prostaglandin E2 by rat renal medullary interstitial cells in culture.

Authors:  T R Beck; A Hassid; M J Dunn
Journal:  J Pharmacol Exp Ther       Date:  1980-10       Impact factor: 4.030

7.  Prostaglandin and thromboxane synthesis by rat glomerular epithelial cells.

Authors:  A S Petrulis; M Aikawa; M J Dunn
Journal:  Kidney Int       Date:  1981-10       Impact factor: 10.612

8.  Lipoxygenase activity in rat kidney glomeruli, glomerular epithelial cells, and cortical tubules.

Authors:  K Jim; A Hassid; F Sun; M J Dunn
Journal:  J Biol Chem       Date:  1982-09-10       Impact factor: 5.157

9.  The localization of circulating immune complexes in experimental serum sickness. The role of vasoactive amines and hydrodynamic forces.

Authors:  W T Kniker; C G Cochrane
Journal:  J Exp Med       Date:  1968-01-01       Impact factor: 14.307

10.  A ROLE OF POLYMORPHONUCLEAR LEUKOCYTES AND COMPLEMENT IN NEPHROTOXIC NEPHRITIS.

Authors:  C G COCHRANE; E R UNANUE; F J DIXON
Journal:  J Exp Med       Date:  1965-07-01       Impact factor: 14.307

View more
  40 in total

1.  Aspirin resistance in hemodialysis patients.

Authors:  Abdallah Sassine Geara; Nassif Azzi; Claude Bassil; Suzanne El-Sayegh
Journal:  Int Urol Nephrol       Date:  2010-07-25       Impact factor: 2.370

Review 2.  Role of arachidonic acid metabolites and reactive oxygen species in glomerular immune-inflammatory process.

Authors:  R Ardaillou; L Baud; J Sraer
Journal:  Springer Semin Immunopathol       Date:  1987

3.  Role of glomerular prostanoid in control of glomerular filtration rate in rats.

Authors:  J Bernheim; E Podjarny; A Pomeranz; M Rathaus
Journal:  Klin Wochenschr       Date:  1988-10-17

4.  The role of eicosanoids in the control of mesangial function.

Authors:  M J Dunn; M S Simonson; P Mené
Journal:  Trans Am Clin Climatol Assoc       Date:  1987

5.  Mesangial cell immune injury. Synthesis, origin, and role of eicosanoids.

Authors:  E A Lianos; B A Bresnahan; C Pan
Journal:  J Clin Invest       Date:  1991-08       Impact factor: 14.808

6.  Increased renal uptake of gentamicin in endotoxemic rats receiving concomitant thromboxane A2 antagonist therapy.

Authors:  M Tardif; Y Bergeron; D Beauchamp; M G Bergeron
Journal:  Antimicrob Agents Chemother       Date:  1993-12       Impact factor: 5.191

7.  Predominant functional roles for thromboxane A2 and prostaglandin E2 during late nephrotoxic serum glomerulonephritis in the rat.

Authors:  K Takahashi; G F Schreiner; K Yamashita; B W Christman; I Blair; K F Badr
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

Review 8.  Current issues in thrombosis prevention with antiplatelet drugs.

Authors:  G de Gaetano; C Cerletti; E Dejana; J Vermylen
Journal:  Drugs       Date:  1986-06       Impact factor: 9.546

9.  Excretion of metabolites of prostacyclin and thromboxane by rats with nephrotoxic nephritis: effects of interleukin-1.

Authors:  P S Ward; R W Fuller; J M Ritter; S J Cashman; A J Rees; C T Dollery
Journal:  Br J Pharmacol       Date:  1991-07       Impact factor: 8.739

10.  Functional significance of renal prostacyclin and thromboxane A2 production in patients with systemic lupus erythematosus.

Authors:  C Patrono; G Ciabattoni; G Remuzzi; E Gotti; S Bombardieri; O Di Munno; G Tartarelli; G A Cinotti; B M Simonetti; A Pierucci
Journal:  J Clin Invest       Date:  1985-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.